154 related articles for article (PubMed ID: 28570672)
1. Mirasol pathogen reduction technology treatment of human whole blood does not induce acute lung injury in mice.
Mallavia B; Kwaan N; Marschner S; Yonemura S; Looney MR
PLoS One; 2017; 12(6):e0178725. PubMed ID: 28570672
[TBL] [Abstract][Full Text] [Related]
2. Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice.
Caudrillier A; Mallavia B; Rouse L; Marschner S; Looney MR
PLoS One; 2015; 10(7):e0133022. PubMed ID: 26176623
[TBL] [Abstract][Full Text] [Related]
3. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model.
Chi X; Zhi L; Vostal JG
Transfusion; 2014 Jan; 54(1):74-85. PubMed ID: 23656563
[TBL] [Abstract][Full Text] [Related]
4. Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.
Silliman CC; Khan SY; Ball JB; Kelher MR; Marschner S
Vox Sang; 2010 May; 98(4):525-30. PubMed ID: 19951305
[TBL] [Abstract][Full Text] [Related]
5. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
Keil SD; Saakadze N; Bowen R; Newman JL; Karatela S; Gordy P; Marschner S; Roback J; Hillyer CD
Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology.
Salunkhe V; De Cuyper IM; Papadopoulos P; van der Meer PF; Daal BB; Villa-Fajardo M; de Korte D; van den Berg TK; Gutiérrez L
Platelets; 2019; 30(3):368-379. PubMed ID: 29553857
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.
Tong S; Wang H; Zhang T; Chen L; Liu B
Mol Med Rep; 2015 Nov; 12(5):7777-81. PubMed ID: 26397744
[TBL] [Abstract][Full Text] [Related]
8. Update on pathogen reduction technology for therapeutic plasma: an overview.
Solheim BG; Seghatchian J
Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
10. Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies.
Vlaar AP; Wolthuis EK; Hofstra JJ; Roelofs JJ; Boon L; Schultz MJ; Lutter R; Juffermans NP
Intensive Care Med; 2010 May; 36(5):879-87. PubMed ID: 20221752
[TBL] [Abstract][Full Text] [Related]
11. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.
Fast LD; DiLeone G; Cardarelli G; Li J; Goodrich R
Transfusion; 2006 Sep; 46(9):1553-60. PubMed ID: 16965583
[TBL] [Abstract][Full Text] [Related]
12. Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI).
Tung JP; Fraser JF; Nataatmadja M; Colebourne KI; Barnett AG; Glenister KM; Zhou AY; Wood P; Silliman CC; Fung YL
Crit Care; 2012 Feb; 16(1):R19. PubMed ID: 22297161
[TBL] [Abstract][Full Text] [Related]
13. The Epidemiology of Transfusion-related Acute Lung Injury Varies According to the Applied Definition of Lung Injury Onset Time.
Vande Vusse LK; Caldwell E; Tran E; Hogl L; Dinwiddie S; López JA; Maier RV; Watkins TR
Ann Am Thorac Soc; 2015 Sep; 12(9):1328-35. PubMed ID: 26102516
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets.
Mastroianni MA; Llohn AH; Akkök ÇA; Skogheim R; Ødegaard ER; Nybruket MJ; Flesland A; Mousavi SA
Transfus Apher Sci; 2013 Oct; 49(2):285-90. PubMed ID: 23820429
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury.
Kapur R; Kim M; Shanmugabhavananthan S; Liu J; Li Y; Semple JW
Blood; 2015 Dec; 126(25):2747-51. PubMed ID: 26453659
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the pathological events involved in immune and non-immune TRALI models.
Tamarozzi MB; Soares SG; Sá-Nunes A; Paiva HH; Saggioro FP; Garcia AB; Lucena-Araujo AR; Falcão RP; Bordin JO; Rego EM
Vox Sang; 2012 Nov; 103(4):309-21. PubMed ID: 22624696
[TBL] [Abstract][Full Text] [Related]
17. Methylprednisolone fails to attenuate lung injury in a mouse model of transfusion related acute lung injury.
Müller MC; Tuinman PR; van der Sluijs KF; Boon L; Roelofs JJ; Vroom MB; Juffermans NP
Transfusion; 2014 Apr; 54(4):996-1001. PubMed ID: 24032748
[TBL] [Abstract][Full Text] [Related]
18. Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.
Zeddies S; De Cuyper IM; van der Meer PF; Daal BB; de Korte D; Gutiérrez L; Thijssen-Timmer DC
Transfusion; 2014 Sep; 54(9):2292-300. PubMed ID: 24689812
[TBL] [Abstract][Full Text] [Related]
19. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
Picker SM; Steisel A; Gathof BS
Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
[TBL] [Abstract][Full Text] [Related]
20. The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial.
Kasirye R; Hume HA; Bloch EM; Lubega I; Kyeyune D; Shrestha R; Ddungu H; Musana HW; Dhabangi A; Ouma J; Eroju P; de Lange T; Tartakovsky M; White JL; Kakura C; Fowler MG; Musoke P; Nolan M; Grabowski MK; Moulton LH; Stramer SL; Whitby D; Zimmerman PA; Wabwire D; Kajja I; McCullough J; Goodrich R; Quinn TC; Cortes R; Ness PM; Tobian AAR
Trials; 2022 Apr; 23(1):257. PubMed ID: 35379302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
